How To Improve Diversity And Inclusion: Five Companies Share Best Practices

Company strategies at improving diversity, equity and inclusion both within their organizations and in the clinical trials they conduct have differed, but building trust is a common theme.

Five companies shortlisted for the Citeline Awards • Source: Alamy

Between the pandemic and the rise of the Black Lives Matter movement in the US, biopharma companies have made it a priority in the past few years to improve diversity and inclusion. After talking to several companies shortlisted for their diversity and inclusion efforts in clinical research for the Citeline Awards, In Vivo identified some common themes that can help other companies looking to improve their own D&I work.

The biggest challenges included building trust and finding ways to reach the communities being targeted. Using local partners and focusing...

More from COVID-19

More from In Vivo

EU Medtech Outlook: The View From MedTech Europe Experts

 
• By 

MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.

‘Confident In Lorundrostat’s Promise’: Mineralys CEO Talks Trials And Next Steps

 

In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.

BioBytes: Qubit Pharmaceuticals Unveils Quantum AI Model For Drug Discovery

 
• By 

Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.